Edition:
India

Horizon Pharma PLC (HZNP.OQ)

HZNP.OQ on NASDAQ Stock Exchange Global Select Market

24.49USD
11:02pm IST
Change (% chg)

$-0.43 (-1.73%)
Prev Close
$24.92
Open
$24.79
Day's High
$24.99
Day's Low
$24.22
Volume
218,381
Avg. Vol
585,478
52-wk High
$29.44
52-wk Low
$12.58

About

Horizon Pharma Public Limited Company is a biopharmaceutical company. The Company is focused on identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. As of December 31, 2016, the Company marketed 11 medicines through its orphan, rheumatology and primary... (more)

Overall

Beta: 1.31
Market Cap(Mil.): $2,211.82
Shares Outstanding(Mil.): 163.35
Dividend: --
Yield (%): --

Financials

  HZNP.OQ Industry Sector
P/E (TTM): -- 29.30 32.55
EPS (TTM): -2.69 -- --
ROI: -13.86 14.23 13.83
ROE: -36.88 15.46 15.25

Recordati to seek Canadian approval for kidney disease drug

TORONTO Italy's Recordati said on Tuesday it plans to seek Canadian approval for its drug Cystagon, which treats a rare kidney disease, in a potential blow to Horizon Pharma,, which makes the only drug approved for treatment in Canada.

16 Apr 2019

Recordati to seek Canadian approval for kidney disease drug

TORONTO, April 16 Italy's Recordati said on Tuesday it plans to seek Canadian approval for its drug Cystagon, which treats a rare kidney disease, in a potential blow to Horizon Pharma,, which makes the only drug approved for treatment in Canada.

16 Apr 2019

Earnings vs. Estimates